Olaris CEO, Dr. Elizabeth O'Day, profiled in HubWeek's Change Marker series

What are Olaris' BoRs and how will they fundamentally change the way diseases are treated? Learn about our Biomarkers of Response and Olaris' mission here! 

Olaris, Inc

35 Gatehouse Drive

Waltham, Massachusetts


e: info@olarisBoR.com

  • Grey LinkedIn Icon
  • Grey Facebook Icon
  • Twitter

© 2021 Olaris, Inc